Five novel intragenic dimorphisms in the human interleukin-1 genes combine to high informativity

被引:77
作者
Guasch, JF
Bertina, RM
Reitsma, PH
机构
[1] Lab. for Exp. Internal Medicine, Academic Medical Center, Amsterdam
[2] Hemostasis and Thromb. Res. Center, Building 1, Leiden University Hospital, Leiden
关键词
haplotype; IL-1B; IL-1RN; polymorphisms;
D O I
10.1006/cyto.1996.0080
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The cytokine interleukin-1 (IL-1) plays a key role in the pathogenesis of inflammatory and immune diseases. Several disease-genotype association studies have addressed the question whether genetic determinants of outcome or severity of disease exist. These studies were hampered by the lack of highly polymorphic markers in the interleukin-1 beta (IL-1B) and IL-1 receptor antagonist (IL-1RN) genes. Polymorphisms in these two genes were searched for in order to increase informativity. Here a novel BsoF I dimorphism and the characterization and PCR detection of a previously identified Taq I polymorphism in the IL-1B gene is reported. Furthermore, in the IL-1RN gene four novel diallelic markers were identified. Little linkage disequilibrium is observed between the two markers in IL-1B gene. Similarly, some of the markers in IL-1RN gene show little linkage disequilibrium. Using the markers described here it is possible to reach a better level of informativity in genotype-disease association studies. (C) 1996 Academic Press Limited
引用
收藏
页码:598 / 602
页数:5
相关论文
共 28 条
[1]   CHARACTERIZATION OF POLYMORPHISMS OF AN INTERLEUKIN-1 RECEPTOR-TYPE-1 GENE (IL1RI) PROMOTOR REGION (P2) AND THEIR RELATION TO INSULIN-DEPENDENT DIABETES-MELLITUS (IDDM) [J].
BERGHOLDT, R ;
KARLSEN, AE ;
JOHANNESEN, J ;
HANSEN, PM ;
DINARELLO, CA ;
NERUP, J ;
POCIOT, F .
CYTOKINE, 1995, 7 (07) :727-733
[2]   ASSOCIATION OF GRAVES-DISEASE WITH AN ALLELE OF THE INTERLEUKIN-1 RECEPTOR ANTAGONIST GENE [J].
BLAKEMORE, AIF ;
WATSON, PF ;
WEETMAN, AP ;
DUFF, GW .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (01) :111-115
[3]   INTERLEUKIN-1 RECEPTOR ANTAGONIST GENE POLYMORPHISM AS A DISEASE SEVERITY FACTOR IN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
BLAKEMORE, AIF ;
TARLOW, JK ;
CORK, MJ ;
GORDON, C ;
EMERY, P ;
DUFF, GW .
ARTHRITIS AND RHEUMATISM, 1994, 37 (09) :1380-1385
[4]  
CLARK BD, 1986, NUCLEIC ACIDS RES, V14, P7879
[5]  
CLAY FE, 1994, HUM GENET, V94, P407
[6]   INTERLEUKIN-1 TYPE-II RECEPTOR - A DECOY TARGET FOR IL-1 THAT IS REGULATED BY IL-4 [J].
COLOTTA, F ;
RE, F ;
MUZIO, M ;
BERTINI, R ;
POLENTARUTTI, N ;
SIRONI, M ;
GIRI, JG ;
DOWER, SK ;
SIMS, JE ;
MANTOVANI, A .
SCIENCE, 1993, 261 (5120) :472-475
[7]  
CORK MJ, 1993, J INVEST DERMATOL, V100, P552
[8]  
DINARELLO CA, 1991, BLOOD, V77, P1627
[9]  
DINARELLO CA, 1993, NEW ENGL J MED, V328, P106
[10]   THE INTERLEUKIN-1 FAMILY - 10 YEARS OF DISCOVERY [J].
DINARELLO, CA .
FASEB JOURNAL, 1994, 8 (15) :1314-1325